Third, the study was conducted at a single center with a relatively modest sample size, potentially limiting generalizability
Acetyl L-carnitine (ALC) is a special form of L-carnitine, an amino acid that the body uses to turn fat into energy
One in three women undergoing axillary lymph node dissection and radiotherapy will develop this incurable and disabling disease ( As far back as 1957 studies have shown that obesity can increase the risk of secondary lymphedema ( Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally brought to market as treatments for diabetes, and were noted to induce weight loss ( Although weight loss has been reported to be beneficial in the treatment of lymphedema, no studies to date have examined the use of GLP-1RAs for the treatment of secondary lymphedema
However, we recognize that every patient is unique
This is likely due to its role in supporting mitochondrial function, the energy-producing structures within cells
Unlike GLP 1 alone, GLP 1 & GIP therapy includes receptor agonists, making it even more effective in promoting weight loss and metabolic benefits